Peeter Karihtala

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Squamous Cell Carcinoma

Early Breast Cancer

Top Venues

Oxidative medicine and cellular longevity

Breast cancer research : BCR

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Iida Tuunanen, Ari Hautakoski, Heikki Huhtamäki, Martti Arffman, Reijo Sund, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Elina Urpilainen
The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Biomedicines 12 (8) (2024)
Iida Tuunanen, Ari Hautakoski, Heikki Huhtamäki, Martti Arffman, Reijo Sund, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Elina Urpilainen
The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Biomedicines 12 (8) (2024)
Peeter Karihtala, Suvi-Katri Leivonen, Ulla Puistola, Elina Urpilainen, Anniina Jääskeläinen, Sirpa Leppä, Arja Jukkola
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast cancer research : BCR 26 (1) (2024)
Peeter Karihtala, Outi Kilpivaara, Katja Porvari
Mutational signatures and their association with cancer survival and gene expression in multiple cancer types. International journal of cancer (2024)
Peeter Karihtala, Suvi-Katri Leivonen, Ulla Puistola, Elina Urpilainen, Anniina Jääskeläinen, Sirpa Leppä, Arja Jukkola
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast cancer research : BCR 26 (1) (2024)
Peeter Karihtala, Suvi-Katri Leivonen, Ulla Puistola, Elina Urpilainen, Anniina Jääskeläinen, Sirpa Leppä, Arja Jukkola
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast cancer research : BCR 26 (1) (2024)
Peeter Karihtala, Suvi-Katri Leivonen, Ulla Puistola, Elina Urpilainen, Anniina Jääskeläinen, Sirpa Leppä, Arja Jukkola
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast cancer research : BCR 26 (1) (2024)
Peeter Karihtala, Katja Porvari, Nelli Roininen, Sari Voutilainen, Johanna Mattson, Päivi Heikkilä, Kirsi-Maria Haapasaari, Katri Selander
Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas. Oncogenesis 11 (1) (2022)
Sylvia Myller, Arja Jukkola, Anniina Jääskeläinen, Nelli Roininen, Peeter Karihtala
How breast cancer recurrences are found - a real-world, prospective cohort study. Acta oncologica (Stockholm, Sweden) 61 (4) (2022)
Anni Immonen, Kirsi-Maria Haapasaari, Sini Skarp, Peeter Karihtala, Hanna-Riikka Teppo
NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma. Oxidative medicine and cellular longevity 2022 (2022)
Peeter Karihtala, Anniina Jääskeläinen, Nelli Roininen, Arja Jukkola
Real-world, single-centre prospective data of age at breast cancer onset: focus on survival and reproductive history. BMJ open 11 (1) (2021)
Peeter Karihtala, Anniina Jääskeläinen, Nelli Roininen, Arja Jukkola
Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital. BMJ open 10 (10) (2020)
Sylvia Myller, Pieta Ipatti, Anniina Jääskeläinen, Kirsi-Maria Haapasaari, Arja Jukkola, Peeter Karihtala
Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses. Acta oncologica (Stockholm, Sweden) 59 (9) (2020)
Mari Hämäläinen, Hanna-Riikka Teppo, Sini Skarp, Kirsi-Maria Haapasaari, Katja Porvari, Katri Vuopala, Thomas Kietzmann, Peeter Karihtala
NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs. Oxidative medicine and cellular longevity 2019 (2019)
Mayu Hosio, Elina Urpilainen, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund, Ulla Puistola, Esa Läärä, Arja Jukkola, Peeter Karihtala
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast cancer research and treatment 175 (3) (2019)
Anniina Jääskeläinen, Arja Jukkola, Kirsi-Maria Haapasaari, Päivi Auvinen, Ylermi Soini, Peeter Karihtala
Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer. Anticancer research 39 (11) (2019)
Tiia J Honkanen, Antti Tikkanen, Peeter Karihtala, Markus Mäkinen, Juha P Väyrynen, Jussi P Koivunen
Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer. Scientific reports 9 (1) (2019)
Anniina Jääskeläinen, Arja Jukkola, Juha Risteli, Kirsi-Maria Haapasaari, Peeter Karihtala
Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 41 (5) (2019)
Elina Urpilainen, Jenni Kangaskokko, Ulla Puistola, Peeter Karihtala
Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 41 (1) (2019)
Pekka Peroja, Mette Pedersen, Tuomo Mantere, Peter Nørgaard, Jenni Peltonen, Kirsi-Maria Haapasaari, Jan Böhm, Esa Jantunen, Taina Turpeenniemi-Hujanen, Katrin Rapakko, Peeter Karihtala, Ylermi Soini, Kaija Vasala, Outi Kuittinen
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP. Scientific reports 8 (1) (2018)
Nelli Roininen, Kirsi-Maria Haapasaari, Peeter Karihtala
The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. Oxidative medicine and cellular longevity 2017 (2017)
Hanna-Riikka Teppo, Ylermi Soini, Peeter Karihtala
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy. Oxidative medicine and cellular longevity 2017 (2017)
Peeter Karihtala, Katja Porvari, Ylermi Soini, Kirsi-Maria Haapasaari
Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas. Oxidative medicine and cellular longevity 2017 (2017)